Healthcare Professionals
Aquamantys System
and Bipolar Sealers
Du har precis klickat på en länk som tar dig till en annan webbplats. Om du fortsätter kommer du att lämna denna webbplats och gå till en webbplats som drivs av någon annan.
Medtronic Sverige varken granskar eller kontrollerar innehållet på den andra webbplatsen och tar inget ansvar för eventuella affärstransaktioner som du utför där. Din användning av den andra webbplatsen är föremål för användarvillkoren och sekretesspolicyn på den webbplatsen.
Det är möjligt att vissa produkter på den andra platsen inte är godkända i Sverige.
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
Välkommen till vår information för hälso- och sjukvårdspersonal.
Här hittar du produktinformation och annan info framtagen för dig som arbetar inom vården.
Arbetar du inom ett vårdyrke?
Healthcare Professionals
Aquamantys System
and Bipolar Sealers
Many clinical studies have been published about the Aquamantys® System, an innovative surgical device that provides hemostatic sealing of soft tissue and bone, reducing blood loss, transfusion rates and surgical time during spine surgery.1,2
During posterior spinal fusion surgery for deformity, this study showed a significant decrease in estimated blood loss in the bipolar sealer group whether measured in total (435 ± 192mL, compared with 1009 ± 392 mL in the control group; p < 0.001) or per level fused (39 ± 17 mL, compared with 95 ± 33 mL in the control group; p < 0.001). In turn, this decreased blood loss resulted in a significantly reduced risk of transfusion (p = 0.014).
This 70-patient study in severe neuromuscular scoliosis demonstrated a reduced operative blood loss, a decrease in the amount of blood transfused, and reduction in overall operative time when the bipolar sealer was used as an adjunct to the author’s conventional blood management strategy.
In a study of 60 patients undergoing multi-level (2-5 level) spine surgery from a posterior approach, the researchers demonstrated that Transcollation® technology resulted in a 35% reduction in intra-operative hemoglobin loss (66.2 g hemoglobin loss in the treatment arm vs. 102.4 g in the control arm).
In this retrospective study of 100 patients undergoing posterior spinal fusion for idiopathic scoliosis, baseline characteristics between groups were similar except for the number of levels fused, which was larger in the bipolar sealer group. The results showed that bipolar sealer patients experienced statistically significantly lower total peri-operative blood loss including post-op drain output, intra-operative cell saver transfusion, intra-operative or post-operative transfusions, and total blood volume transfused.
- Society for the Advancement of Blood Management 2009, Kansas City, MO.
- Society for the Advancement of Blood Management 2009; Baltimore, MD
- American Association of Orthopedic Surgeons 2007; San Diego, CA
- Pediatric Orthopaedic Society of North America 2007; Hollywood, FL
- National Association of Orthopaedic Nurses 2007; St. Louis, MO
Mankin KP, Moore CA, Miller LE et al. Hemostasis with a bipolar sealer during surgical correction of adolescent idiopathic scoliosis. J Spinal Disorders & Techniques, October 2011; doi:10.1097/BSD.0b013e3182334ec5.
Snyder BD, Hedequist D, Shannon E. Hemostatic efficacy of bipolar wound sealer as adjunct to wound management in children with neuromuscular scoliosis. Poster presentation at Pediatric Orthopaedic Society of North America Annual Meeting 2007; Hollywood, FL.
Hill SE, Broomer B, Stover J et al. Bipolar tissue sealant device decreases hemoglobin loss in multilevel spine surgery. Transfusion April 2012; doi: 10.1111/j.1537-2995.2012.03649.x
Gordon Z, Poe-Kochert C, Son-Hing J et al. Use of bipolar sealer device reduces blood loss and transfusions in posterior spinal fusion. Poster presentation at American Academy of Orthopaedic Surgeons Annual Meeting 2012; San Francisco, CA; paper number 339.